Table 2: Cytoplasmic and nuclear VDR expression in urinary carcinoma cases.
|
Immunoreactivity score |
Cytoplasmic/Membranous VDR |
Nuclear VDR |
|
|
Negative |
0 |
6 (1.9%) |
29 (46.3%) |
|
1 |
4 (3.7%) |
6 (11.1%) |
|
|
Low |
2 |
9 (11.1%) |
6 (11.1%) |
|
3 |
14 (18.5%) |
11 (11.1%) |
|
|
4 |
6 (9.3%) |
4 (5.6%) |
|
|
High |
6 |
13 (16.7%) |
6 (7.4%) |
|
9 |
22 (38.9%) |
12 (7.4%) |
|
|
n Mean ± STD |
74 4.93 ± 3.13 |
74 3.85 ± 3.27 |
|